J&J Cites Stents, Orthopedics As Key To 9.3% Advance In Q3 Device Sales
This article was originally published in The Gray Sheet
Executive Summary
Johnson & Johnson cited its DePuy orthopedics and Cordis cardiovascular units as key contributors to a 9.3% advance in its Medical Devices and Diagnostics segment sales to $2.78 bil. for the third quarter, announced Oct. 16.